2026 Q3 Corporate Presentation

Upcoming Events

Past Events

Featured
Orum Therapeutics to Participate in NDR Hosted by Mirae Asset
Read more →
Advancing ORM-1153 into the Clinic: Conference Call on IND Clearance & Clinical Study Overview
Read more →
Orum to participate in Shinhan Bio Forum in Daejeon
Read more →
Orum to participate in KOSDAQ CONNECT 2026
Read more →
Orum to participate in a Hong Kong NDR, co-hosted by HSBC and Mirae Asset Securities 
Read more →
Notice of the 10th Annual General Meeting 2026

Webcast Registration

Read more →
J.P. Morgan Healthcare Conference
Read more →
ASH Annual Meeting
Read more →
Corporate Day Hosted by Mirae Asset
Read more →
UBS Global Healthcare Conference
Read more →
2025 Extraordinary General Meeting
Read more →
NDR (Non-Deal Roadshow) Hosted by Samsung Securities
Read more →
UBS Asian Investment Conference 2025
Read more →
Samsung Global Investors Conference 2025
Read more →
2025 9th Annual General Meeting
Read more →
2024 Annual Result Conference Call
Read more →
Orum Therapeutics to Host Fourth Quarter 2024 Earnings Conference Call
Read more →
UBS Asia Healthcare Corporate Day - Hong Kong 2024

Read more →
Orum Therapeutics to Hold Analyst Day in Korea
Read more →
Orum Therapeutics to Host a Global Media Conference Call for the IPO

Read more →
Orum Therapeutics Announces Three Presentations At AACR 2023
Read more →
Orum Therapeutics Presents Positive Preclinical Data Of ORM-6151 at ASH 2022
Read more →
Orum Therapeutics Presents Positive Preclinical Data Of ORM-6151, A First-In-Class, CD33-GSPT1 Dual-Precision Targeted Protein Degrader For AML, At ASH 2022
Read more →
­Orum Therapeutics Presents Preclinical Data At AACR 2022 Highlighting Novel Dual-Precision Targeted Protein Degrader, ORM-5029, Degrading GSPT1
Read more →